Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasuyuki Takahashi
Observed name:
Yasuyuki, Takahashi
Institutions:
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
Observed institutions:
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
ORCID:
0009-0005-4033-0180
Observed ORCID:
0009-0005-4033-0180
OpenAlex ID:
A5103836626
The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders
2020
·
Michihide Tokuhira
, Yuka Tanaka
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
19
PDF
The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis
2017
·
Michihide Tokuhira
, Takayuki Tabayashi
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
12
PDF
[Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis].
2018
·
Yuka Tanaka
, Yasuyuki Takahashi
, et al.
·
PubMed
·
5
Targeting the Wnt/β-Catenin Signaling Pathway in Multiple Myeloma: A Possible New Therapeutic Approach to Overcome Bortezomib-Resistance
2014
·
Takayuki Tabayashi
, Yasuyuki Takahashi
, et al.
·
Blood
·
5
Inhibition of WEE1 Induces Cell Death of Both Bortezomib- and Lenalidomide-Resistant Multiple Myeloma Cells: A Novel Therapeutic Approach Targeting Cell-Cycle Checkpoint Kinase
2016
·
Takayuki Tabayashi
, Yuka Tanaka
, et al.
·
Blood
·
4
Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury
2016
·
Reiko Watanabe
, Takayuki Tabayashi
, et al.
·
International Journal of Hematology
·
4
Complexity and Challenges of Translating the Dark Zone Signature Into Immunohistochemistry in Diffuse Large B-Cell Lymphoma
2026
·
Shuji Momose
, Keisuke Sawada
, et al.
·
Modern Pathology
·
2
Dual Targeting of Cell-Cycle Checkpoint Kinase and Unfolded Protein Response As a Novel Therapeutic Approach for High-Risk Multiple Myeloma with TP53 Deletion or Mutations
2018
·
Yuka Tanaka
, Takayuki Tabayashi
, et al.
·
Blood
·
2
The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders
2018
·
Michihide Tokuhira
, Yuta Kimura
, et al.
·
Blood
·
1
Abstract 1884: Dual targeting of cell cycle checkpoint and histone deacetylase overcomes bortezomib resistance in multiple myeloma
2018
·
Takayuki Tabayashi
, Yuka Tanaka
, et al.
·
Cancer Research
·
1
Efficacy of Low-Dose Cytarabine-Based Regimen(Cag)Followed by Azacitidine for Elderly Patients with Mds/Aml
2014
·
Takayuki Tabayashi
, Yasuyuki Takahashi
, et al.
·
Annals of Oncology
·
1
PDF
Development and Internal Validation of the AB-IPI using Bootstrapping: A Clinicopathological Prognostic Score Integrating Host Fitness and Tumor Biology in Diffuse Large B-Cell Lymphoma
2026
·
Noriyuki Sakata
, Yuka Tanaka
, et al.
·
medRxiv
PDF
AB-IPI: A Clinicopathological Prognostic Score Integrating Host Fitness and Tumor Biology in Diffuse Large B-Cell Lymphoma
2026
·
Noriyuki Sakata
, Yuka Tanaka
, et al.
·
Research Square
PDF
Systemic, asymptomatic skeletal muscle infiltration by MALT lymphoma: Defining a 'silent infiltrator' phenotype with 18F-FDG PET/CT
2026
·
Yasuyuki Takahashi
, Ken Naganuma
, et al.
·
Leukemia Research Reports
Successful Treatment of Disseminated Nocardiosis by Rapid Identification of the Organism via Genetic Analysis in a Leukemia Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2024
·
Tomoe Anan
, Yasuyuki Takahashi
, et al.
·
Cureus
PDF
HL-252 MCVAC Conditioning Regimen Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed and Refractory Hodgkin Lymphoma: A Single-Institution Retrospective Study
2023
·
Ken Naganuma
, Yasuyuki Takahashi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: HL-252 MCVAC Conditioning Regimen Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed and Refractory Hodgkin Lymphoma: A Single-Institution Retrospective Study
2023
·
Ken Naganuma
, Yasuyuki Takahashi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
[Acute lymphoblastic leukemia with "masked" Philadelphia chromosome].
2022
·
Ken Naganuma
, Takayuki Tabayashi
, et al.
·
PubMed
[De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
2022
·
Takeaki Matsunaga
, Ken Naganuma
, et al.
·
PubMed
Up-front high-dose chemotherapy followed by autologous stem cell transplantation for high-risk aggressive lymphoma
2017
·
Yuka Tanaka
, Takayuki Tabayashi
, et al.
·
Annals of Oncology
CD14-CD15+, Possible Cells Are Potent Myeloid-Derived Suppressor Cells, Which Affect the Pathogenesis of Induction and Regression in Methotrexate-Mediated Lymphoproliferative Disorders
2016
·
Michihide Tokuhira
, Shuntaro Saito
, et al.
·
Blood
Novel Therapeutic Approach to Overcome Both Bortezomib- and Lenalidomide-Resistant Multiple Myeloma By Targeting TOPK/PBK
2015
·
Takayuki Tabayashi
, Yasuyuki Takahashi
, et al.
·
Blood
Therapeutic approach for primary plasma cell leukemia: case reports and a review of the literature
2015
·
Takayuki Tabayashi
, Yasuyuki Takahashi
, et al.
·
Annals of Oncology
PDF
Successful Management of Transplant-Ineligible Patients with Refractory/Relapsed Multiple Myeloma By Using a Biweekly or Longer Modified Bortezomib Schedule As Interval Maintenance therapy
2014
·
Michihide Tokuhira
, Yuta Kimura
, et al.
·
Blood
Show more works
View as search
Works count:
25
Citation count:
56
H-index:
4
I10-index:
2
Year
Topic
Type